FamiCord AG – Particular Name

Operator

Good day, everybody, and a heat welcome once more to the Poland convention on air to those that attended some additional calls. And now I am delighted to welcome FamiCord AG and the CEO, Jakub Baran. So he would be the final presentation, however not the least. So now we’re joyful to see what FamiCord is doing. And sure, you’re going to get us by way of some insights and the presentation, Jakub. So now the stage is yours.

Jakub Baran
Chairman of the Administration Board & CEO

Thanks — thanks very a lot. Welcome, everyone. This time from our Warsaw workplace. I share my time between Leipzig and Warsaw. And I’ll let you know, I’ll stroll you thru a presentation of our firm named FamiCord, which we imagine is simply one thing greater than stem cell financial institution.

So to start with, why we’re right here at Poland ON AIR. A number of years in the past, Polish firm known as komorek macierzystych did a cross-border merger with German listed firm known as Vita 34 AG. And Vita on the time was listed at Deutsche Borse and we’re listed on the Warsaw Inventory Alternate. So on the time, Vita merely bought PBKM, paying in shares and partially in money. Actually, that transaction was a reversal takeover as PBKM was a lot bigger firm on the time and was by far the biggest stem cell financial institution in Europe.

After that merger, which is fairly uncommon, and we predict it is relatively even distinctive operations between mid-cap corporations between Polish and German inventory exchanges, PBKM was delisted from Warsaw Inventory Alternate, and now we’re listed solely at